Signal Analysis for Neurocritical Patients
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03362346|
Recruitment Status : Completed
First Posted : December 5, 2017
Last Update Posted : June 6, 2018
|Condition or disease||Intervention/treatment|
|Brain Injuries, Acute||Device: intracranial pressure monitoring|
|Study Type :||Observational|
|Actual Enrollment :||156 participants|
|Official Title:||Analysis of Physiological Signals From Neurocritical Patients in Intensive Care Units Using Wavelet Transform and Deep Learning|
|Actual Study Start Date :||December 18, 2017|
|Actual Primary Completion Date :||May 24, 2018|
|Actual Study Completion Date :||May 31, 2018|
Patients with brain injury from trauma, ischemic stroke, hemorrhage stroke (intracerebral hemorrhage, subarachnoid hemorrhage), brain tumor with increased intracranial pressure, brain infection, hydrocephalus, among others.
Device: intracranial pressure monitoring
The patients may have either intracranial pressure (ICP) monitor insertion or external ventricular drainage that can be used as ICP monitor.
Other Name: physiological monitoring
- Neurological status [ Time Frame: Discharge out of the intensive care unit, averaged 2 weeks ]Glasgow coma scale/Mortality
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03362346
|Far Eastern Memorial Hospital|
|New Taipei City, Taiwan, 200|
|Principal Investigator:||Yi-Hsin Tsai, M.D.||Far Eastern Memorial Hospital|